U.S. markets open in 9 hours 30 minutes
  • S&P Futures

    4,465.25
    +36.25 (+0.82%)
     
  • Dow Futures

    35,191.00
    +407.00 (+1.17%)
     
  • Nasdaq Futures

    15,144.25
    +107.00 (+0.71%)
     
  • Russell 2000 Futures

    2,264.10
    -8.00 (-0.35%)
     
  • Crude Oil

    82.66
    +1.35 (+1.66%)
     
  • Gold

    1,768.10
    -29.80 (-1.66%)
     
  • Silver

    23.35
    -0.13 (-0.54%)
     
  • EUR/USD

    1.1606
    +0.0005 (+0.05%)
     
  • 10-Yr Bond

    1.5760
    +0.0570 (+3.75%)
     
  • Vix

    16.30
    -0.56 (-3.32%)
     
  • GBP/USD

    1.3751
    +0.0074 (+0.54%)
     
  • USD/JPY

    114.2000
    +0.5230 (+0.46%)
     
  • BTC-USD

    62,105.66
    +964.75 (+1.58%)
     
  • CMC Crypto 200

    1,464.06
    +57.32 (+4.07%)
     
  • FTSE 100

    7,234.03
    +26.32 (+0.37%)
     
  • Nikkei 225

    29,068.63
    +517.70 (+1.81%)
     

Weekly CFO Buys Highlight

  • Oops!
    Something went wrong.
    Please try again later.
·3 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

According to GuruFocus Insider Data, the recent Chief Financial Officer (CFO) buys were for RCM Technologies Inc. (NASDAQ:RCMT), Digirad Corp (NASDAQ:DRAD) and Cellectar Biosciences Inc. (CLRB).

RCM Technologies Inc. CFO Kevin D. Miller bought 150,000 shares

CFO Kevin D. Miller bought 150,000 shares for $1.20 per share on June 2. Since then, the stock price has increased by 62.5%. RCM Technologies Inc. has a market cap of $22.04 million and its shares were traded around $1.95. The company has a price-sales ratio of 0.14.


RCM Technologies Inc. announced its first-quarter results with revenue of $45.03 million and gross profit of $10.84 million, while the net loss was $5.95 million. The 2019 total revenue was $191.10 million, a 0.5% decrease from 2018. The gross profit was $48.59 million, a 1% decrease from the year prior. The net loss was $4.06 million.

Director Roger H. Ballou bought 100,000 shares for $1.20 per share on June 2. Since then, the stock price has increased by 62.5%.

Bradley Vizi bought 850,000 shares for $1.20 per share on June 2. Since then, the stock price has increased by 62.5%.

Digirad Corp Chief Operating Officer and CFO David J. Noble bought 20,000 shares

Chief Operating Officer and CFO David J. Noble bought 20,000 shares for $2.24 per share on May 28. Since then, the stock price has increased by 34.82%. Digirad Corp has a market cap of $13.060 million and its shares were traded around $3.02. The company has a price-sales ratio of 0.05.

Digirad Corp announced its first-quarter results with revenue of $28.86 million and gross profit of $4.44 million, while the net loss was $2.95 million. The 2019 total revenue was $114.19 million, a 10% increase from 2018. The gross profit was $22.12 million, a 7% increase from the year prior. The net loss was $4.63 million.

President and CEO Matthew G. Molchan bought 2,000 shares for $2.24 per share on May 28. Since then, the stock price has increased by 34.82%.

Director Jeffrey E. Eberwein bought 44,000 shares for $2.24 per share on May 28. Since then, the stock price has increased by 34.82%.

Director Michael A. Cunnion bought 5,000 shares for $2.24 per share on May 28. Since then, the stock price has increased by 34.82%.

Director Mitchell I Quain bought 22,000 shares for $2.24 per share on May 28. Since then, the stock price has increased by 34.82%.

Cellectar Biosciences Inc. CFO Dov Elefant bought 4,348 shares

CFO Dov Elefant bought 4,348 shares for $1.15 per share on June 5. Since then, the stock price has increased by 2.61%. Cellectar Biosciences Inc. has a market cap of $11.080 million and its shares were traded around $1.18. Over the past 10 years, Cellectar Biosciences Inc. had an annual average earnings growth of 57.00%.

President and CEO James V. Caruso bought 21,740 shares for $1.15 per share on June 5. Since then, the stock price has increased by 2.61%.

Chief Business Officer Jarrod Longcor bought 65,218 shares for $1.15 per share on June 5. Since then, the stock price has increased by 2.61%.

Director Stephen A. Hill bought 18,000 shares for $1.08 per share on June 4. Since then, the stock price has increased by 9.26%.

Disclosure: none

Not a Premium Member of GuruFocus? Sign up for a free 7-day trial here.


This article first appeared on GuruFocus.